Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

Medical Management Post AVR

Presenter: Javed Butler

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

Presentation TCT 2023

I Have a Crystal Ball: What Will the AVR Universe Look Like in 2030?

Presenter: Bernard Prendergast

October 25, 2023

Presentation TCT 2022

Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?

Presenter: David Wood

September 17, 2022

Presentation TVT 2022

Matching Valve Durability with Life Expectancy after AVR:

Presenter: James Harvey

June 09, 2022

Presentation Live Valves 2019

Aortic Insufficiency: Repair vs. Replacement?

Presenter: Evaldas Girdauskas

December 10, 2019

Presentation TCT Abstracts Posters 2019

Minimally Invasive Allograft Implantation in Elective Aortic Valve Surgery: Aortic Homograft New Implantation Technique and Ministernotomy Ross Procedure

Presenter: Miklós Bitay

September 29, 2019

Presentation TVT 2019

Smaller Aortic Annular Area Is Associated With Patient Prosthesis Mismatch in TAVR, but Not Surgical AVR

Presenter: Amogh Karnik

June 14, 2019

Presentation TVT 2019

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Presenter: Rashad Belin

June 13, 2019

Presentation EuroPCR 2019

Prosthetic valve endocarditis after transcatheter or surgical AVR with a bioprosthesis Results from the FinnValve registry

Presenter: Noriaki Moriyama

May 21, 2019

Presentation ECHO/IMAGING 2019

Case: 80 yo female with prior AVR

Presenter: Jeremy Thaden

March 23, 2019

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Presenter: Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Mitral Annular Ring Dehisence Between Initial TTE and Pre-AVR Intraop TEE

Presenter: Isaac George, Christopher U. Meduri, Shahzad Shah, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani

June 21, 2018

Presentation

Valve-in-Valve TAVR vs Redo Surgical AVR for Bioprosthetic Aortic Valve Dysfunction

April 25, 2018

Presentation

Frailty in Older Adults Undergoing AVR:The FRAILTY-AVR Study

July 12, 2017

Advertisement

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Medical Management Post AVR

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

I Have a Crystal Ball: What Will the AVR Universe Look Like in 2030?

Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?

Matching Valve Durability with Life Expectancy after AVR:

Aortic Insufficiency: Repair vs. Replacement?

Minimally Invasive Allograft Implantation in Elective Aortic Valve Surgery: Aortic Homograft New Implantation Technique and Ministernotomy Ross Procedure

Smaller Aortic Annular Area Is Associated With Patient Prosthesis Mismatch in TAVR, but Not Surgical AVR

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Prosthetic valve endocarditis after transcatheter or surgical AVR with a bioprosthesis Results from the FinnValve registry

Case: 80 yo female with prior AVR

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Mitral Annular Ring Dehisence Between Initial TTE and Pre-AVR Intraop TEE

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Valve-in-Valve TAVR vs Redo Surgical AVR for Bioprosthetic Aortic Valve Dysfunction

Frailty in Older Adults Undergoing AVR:The FRAILTY-AVR Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content